The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rivera, J.
Right arrow Articles by Casadevall, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rivera, J.
Right arrow Articles by Casadevall, A.
The Journal of Immunology, 2005, 174: 8017-8026.
Copyright © 2005 by The American Association of Immunologists

Mouse Genetic Background Is a Major Determinant of Isotype-Related Differences for Antibody-Mediated Protective Efficacy against Cryptococcus neoformans1,2

Johanna Rivera* and Arturo Casadevall3,*,{dagger}

Departments of* Microbiology and Immunology and {dagger} Medicine, Division of Infectious Diseases, Albert Einstein College of Medicine, Bronx, NY 10461

The protective efficacy of mAbs to Cryptococcus neoformans glucuronoxylomannan depends on Ab isotype. Previous studies in A/JCr and C57BL/6J mice showed relative protective efficacy of IgG1, IgG2a >> IgG3. However, we now report that in C57BL/6J x 129/Sv mice, IgG3 is protective while IgG1 is not protective, with neither isotype being protective in 129/Sv mice. IgG1, IgG2a, and IgG3 had different effects on IFN-{gamma} expression in infected C57BL/6J x 129/Sv mice. IgG1-treated C57BL/6J x 129/Sv mice had significantly more pulmonary eosinophilia than IgG2a- and IgG3-treated C57BL/6J x 129/Sv mice. C. neoformans infection and Ab administration had different effects on Fc{gamma}RI, Fc{gamma}RII, and Fc{gamma}RIII expression in C57BL/6J, 129/Sv, and C57BL/6J x 129/Sv mice. Our results indicate that the relative efficacy of Ab isotype function against C. neoformans is a function of the genetic background of the host and that IgG3-mediated protection in C57BL/6J x 129/Sv mice was associated with lower levels of IFN-{gamma} and fewer pulmonary eosinophils. The dependence of isotype efficacy on host genetics underscores a previously unsuspected complex relationship between the cellular and humoral arms of the adaptive immune response.




This article has been cited by other articles:


Home page
CVIHome page
R. Almeida-Paes, M. A. Pimenta, P. C. F. Monteiro, J. D. Nosanchuk, and R. M. Zancope-Oliveira
Immunoglobulins G, M, and A against Sporothrix schenckii Exoantigens in Patients with Sporotrichosis before and during Treatment with Itraconazole
Clin. Vaccine Immunol., September 1, 2007; 14(9): 1149 - 1157.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
O. Zaragoza, M. Alvarez, A. Telzak, J. Rivera, and A. Casadevall
The Relative Susceptibility of Mouse Strains to Pulmonary Cryptococcus neoformans Infection Is Associated with Pleiotropic Differences in the Immune Response
Infect. Immun., June 1, 2007; 75(6): 2729 - 2739.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
N. Macura, T. Zhang, and A. Casadevall
Dependence of Macrophage Phagocytic Efficacy on Antibody Concentration
Infect. Immun., April 1, 2007; 75(4): 1904 - 1915.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
D. O. Beenhouwer, E. M. Yoo, C.-W. Lai, M. A. Rocha, and S. L. Morrison
Human Immunoglobulin G2 (IgG2) and IgG4, but Not IgG1 or IgG3, Protect Mice against Cryptococcus neoformans Infection
Infect. Immun., March 1, 2007; 75(3): 1424 - 1435.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.